Plus he only ordered blood tests every 3 months
I have private insurance and medicare. Medicare requires it to be below 10 or they will mot cover. Nor will my ins, I take 35 weekly to maintain at 10 it sucks.
Recently there has been some discussion about what target range nephs are prescribing for Hemoglobin levels. And it appears that there is quite a range out there. My neph adheres to the "black box warning" on EPO and keeps my Hgb in a relatively low range, one that frequently dips into troublingly low territory (e.g. 8.4 right now). I find that the low Hgb level is one of the greatest enemies of a good quality of life for me and would like to make an argument to raise the target. I'm curious about what others of you are maintained at and how frequenly you get EPO (or similar). Here's an article that SutureSelf submitted about the subject that calls these ranges into question.http://homedialysis.org/life-at-home/articles/anemia-epo-kidney-failure-and-you
My nephrologist wants me to maintain an Hgb of 12. Even during the black box warning craziness, she still allowed me to go as high as 11.5.
As suggested by large RCTs such as the CREATE, CHOIR and TREAT in the Western countries, we think that a target Hb of >13 g/dl may be associated with higher risk of occurrence of CVD [emphasis mine].Hb level of >11 g/dl should be aimed for all the CKD patients. All the international guidelines and our clinical experiences taken together, we should consider administration of ESA when the Hb level becomes <11 g/dl in pre-dialysis patients and 10 g/dl in dialysis patients. The target Hb we should achieve is >10 g/dl in dialysis patients and 11 g/dl in pre-dialysis patients. We recommend that the target Hb should not be >13 g/dl in all the CKD patients.https://www.karger.com/Article/FullText/440849
(sorry, don't know exact dose other than it's the max).
CKD Anemia Treatment in Dialysis Patients: Does it Differ from Pre-Dialysis Patients?It is true that dialysis patients are a different population from pre-dialysis patients, even when anemia issues are considered. In contrast to pre-dialysis patients, patients undergoing dialysis have blood loss through the dialyzer and tubing, a greater degree of iron deficiency (perhaps because of reduced absorption and mobilization of iron), and more inflammation, causing erythropoietin resistance. Generally, epoetin dose requirements appear to be higher for dialysis patients than for pre-dialysis patients. Therefore, it seems to be justified to argue that dialysis patients should be considered a distinct group. However, the significance of conceding this point should not be underestimated. Because there are no ongoing or planned randomized controlled studies evaluating Hgb target levels in dialysis patients, this means that until such a study is published, the status quo ante of aggressively treating the anemia these patients have would prevail. It would also allow CMS to provide dialysis chains the flexibility, through relaxed reimbursement policies, to drive Hgb values beyond the FDA-recommended level of 12 g/dL. However, most importantly, results looking at anemia targets have been similar between dialysis and pre-dialysis patients.Why should physicians treating their dialysis patients aim for Hgb levels12 g/dL? First, because the recent data from the CHOIR study indicated increased deaths and cardiovascular complications with no significant improvement in quality of life in the higher versus lower Hgb group. Second, because the data from studies of dialysis patients (Normal Hematocrit and Canada-Europe studies) and pre-dialysis patients have provided concordant results, indicating the potential for harm to both dialysis and pre-dialysis patients; thus, concerns about differences in the dialysis and pre-dialysis populations are likely exaggerated, at least as they apply to anemia. Third, several studies in cancer and other populations have reported increased risk with aiming for Hgb levels 12 g/dL.Finally, we should defer to the FDA on safety-related issues. The FDA recently issued a black box warning that recom- mended that the Hgb in patients with kidney disease not rise beyond 12 g/dL.27 The black box warning is the most severe warning about the safety of a drug that the FDA issues, and it has resulted in a label change. The FDA is independent and rigorous in its regulatory oversight of drugs. Until a future study supports the safety of a higher Hgb level in kidney patients, we should adhere to the FDA’s advice. D&T
My husband's neph wants his Hemoglobin to be between 10-11. Since it's been hovering around 9+ they have been giving him the maximum dose of EPO 3xweek. (sorry, don't know exact dose other than it's the max). They give him IV Iron as needed and also based on his Serum Ferritin level (which is suppose to be greater than 100). He feels lousy and also looks very pale when his Hemoglobin is below 10.
Quote from: PrimeTimer on September 03, 2016, 03:53:58 PM(sorry, don't know exact dose other than it's the max).There is the max and then there is the max. My record was 50,000 units a week (yes, really). I came out of hip replacement surgery at 6.2 and I was stubbornly refusing the transfusions that resident MDs were writing orders for. (The chief of hemo was kind enough to give one of these residents a nice lecture on why is was reasonable for a dialysis patient to resist transfusions). They let me go home at 6.2 after keeping me a couple of extra days to make sure it stabilized, then it took about 4 weeks before I got up to 8.5 which was the criteria for getting out of my temporary exile to the clinic back to home hemo. I hover a bit over 10 now.When I was on EPO and traveling, I was told to either time my EPO shots so that I would not need any when at the clinic I was visiting or bring my own EPO with me, as clinics would not want to give transients EPO at the bundled rate.
My hemoglobin when I started epo was 7.2 and that was July 28. So it hasn't gone up much. I told my neph my concern of it not going up so she upped it to the 12k last week. I'm Getting discouraged. Is this normal? Its been about a month and 2 weeks.
-the goal remains 10’s (I can finagle low 11’s,that’s it),I hope your friends are not having strokes,since we live in America we follow the FDA-you might need to come in more often for it,otherwise we blast the dose-some resistance from infection-need redo basic workup for OTHER causes of anemia,then if stuck you go see the hematologist-see you Thursday,we’ll get it up
At DCI, ESA doses for 90% of our patients are adjusted by computerized protocols, with a target hemoglobin of between 10 and 12. Patients and doctors can deviate from these protocols. We’ve found that if we stop ESAs when the hemoglobin level exceeds 12, 90% of our patients have values between 10 and 12 for at least 6 months of the year.
At DCI, ESA doses for 90% of our patients are adjusted by computerized protocols, with a target hemoglobin of between 10 and 12.
If her target is 10 and you're at an 8.4, then I don't understand why you're not getting it?